Gilead, AbCellera team up against infectious diseases

13th June 2019 Uncategorised 0

AbCellera will receive upfront and research payments and is eligible to receive downstream clinical and commercial milestone payments and royalties.

More: Gilead, AbCellera team up against infectious diseases
Source: News